CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
125 hedge funds and large institutions have $4.41B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 44 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 44
21% less call options, than puts
Call options by funds: $16.4M | Put options by funds: $20.7M
Holders
125
Holding in Top 10
6
Calls
$16.4M
Puts
$20.7M
Top Buyers
| 1 | +$114M | |
| 2 | +$18.3M | |
| 3 | +$15.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$11.2M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$14.9M | |
| 3 | -$14.8M | |
| 4 |
BCI
Bain Capital Investors
Boston,
Massachusetts
|
-$13.8M |
| 5 |
State Street
Boston,
Massachusetts
|
-$11.7M |